Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

3TZ7

Kinase domain of cSrc in complex with RL103

Summary for 3TZ7
Entry DOI10.2210/pdb3tz7/pdb
Related3F3V 3F3W 3TZ8 3TZ9
DescriptorProto-oncogene tyrosine-protein kinase Src, N-(4-{[4-({[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]carbamoyl}amino)phenyl]amino}quinazolin-6-yl)-4-(dimethylamino)butanamide (2 entities in total)
Functional Keywordstype ii, allosteric, dfg-out, drug resistance mutations, tyrosin-protein kinase, transferase-transferase inhibitor complex, transferase/transferase inhibitor
Biological sourceGallus gallus (Chicken)
Cellular locationCell membrane (By similarity): P00523
Total number of polymer chains2
Total formula weight66726.92
Authors
Gruetter, C.,Richters, A.,Rauh, D. (deposition date: 2011-09-27, release date: 2012-10-10, Last modification date: 2023-11-01)
Primary citationRichters, A.,Getlik, M.,Gruetter, C.,Schneider, R.,Heuckmann, J.M.,Heynck, S.,Sos, M.L.,Thomas, R.K.,Rauh, D.
Overcoming Gatekeeper Mutations in cSrc and Abl by Hybrid Compound Design
To be Published,
Experimental method
X-RAY DIFFRACTION (3.3 Å)
Structure validation

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon